Progressive multifocal leukoencephalopathy: Prolonged survival in patients treated with protease inhibitors and cidofovir: A case series [7]

AIDS

Volumn 20, Issue 5, 2006, Pages 791-793

  Garvey, Lucy ^a   Thomson, Emma C ^a   Taylor, Graham P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; BRAIN BIOPSY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; DIAGNOSTIC IMAGING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JC VIRUS; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL RATE; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BRAIN; CYTOSINE; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; PHOSPHONIC ACIDS; SURVIVAL RATE;

EID: 33745111546     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000216390.83351.87     Document Type: Letter

References (10)

1. Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998; 12:1149-1154.
2. Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, et al. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1998; 12:2467-2472.
3. Dworkin MS, Wan PC, Hanson DL, Jones JL. Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis 1999; 180:621-625.
4. Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999; 52:623-625.
5. Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000; 30:95-99.
6. Berenguer J, Miralles P, Arrizabalaga , Ribera E, Dronda F, Baraia-Etxaburu J, et al., GESIDA 11/99 Study Group. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 2003; 36:1047-1052.
7. Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, et al., Adult AIDS Clinical Trials Croup 363 Team. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 2002; 16:1791-1797.
8. Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 2005; 40:738-744.
9. De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG, et al. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 2000; 14:F117-F121.
10. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004; 17:365-370.